Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer-Reference-Cited by-同舟云学术

Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer

Published:2019-12 Issue: Volume:2 Page:100008
ISSN:2589-9090
Container-title:Journal of Translational Autoimmunity
language:en
Short-container-title:Journal of Translational Autoimmunity

Author:

Jain Alka,Shah Haikoo,Simonsick Eleanor M.,Metter E. Jeffrey,Mangold Leslie,Humphreys Elizabeth,Partin Alan,Fedarko Neal S.

Funder

Congressionally Directed Medical Research Programs

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor;Wallukat;J. Clin. Investig.,1999

2. Activating auto-antibodies against the AT1 receptor in preeclampsia;Dechend;Autoimmun. Rev.,2005

3. Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor;Yang;Cardiovasc. Toxicol.,2014

4. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection;Dragun;N. Engl. J. Med.,2005

5. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss;Giral;Am. J. Transplant.,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia;Journal of the American Heart Association;2021-06-15

2. Autoimmunity in 2019;Clinical Reviews in Allergy & Immunology;2020-07-29